Achieve Life Sciences Inc expected to post a loss of 31 cents a share - Earnings Preview

Achieve Life Sciences

26/03/2024 20:36

* Achieve Life Sciences Inc  ACHV.OQ   ACHV.O  is expected
to show
no change in quarterly revenue when it reports  results on March
28 for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Achieve Life Sciences
Inc is
for a loss of 31 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Achieve
Life
Sciences Inc is $18.00​, above​ its last closing price of $4.67.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.37       -0.38      -0.34     Beat    10.2
 Jun. 30 2023  -0.41       -0.42      -0.43     Missed  -2
 Mar. 31 2023  -0.68       -0.69      -0.50     Beat    27.1​
 Dec. 31 2022  -0.77       -0.83      -0.83     Met     0
 ​​Sep.        -1.14       -1.13      -1.35     Missed  -19.8
 30 2022                                                
 Jun. 30 2022  -0.83       -0.83      -1.08     Missed  -29.5​
 Mar. 31 2022  -0.79       -0.81      -0.80     Beat    1.5
 Dec. 31 2021  -0.70       -0.69      -0.76     Missed  -9.9
 This summary was machine generated March 26 at 20:36 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)